SynthesisDiabetes care2023

Cardiovascular and Renal Benefits of Novel Diabetes Drugs by Baseline Cardiovascular Risk: A Systematic Review, Meta-analysis, and Meta-regression.

José M Rodriguez-Valadez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.